無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の軟組織同種移植片市場の分析:移植片タイプ、用途、エンドユーザー、地域別(2018年〜2023年)

Global Soft Tissue Allografts Market - Segmented by Soft Tissue Allograft Type, Application, End-User and Geography - Growth, Trends and Forecast (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 707236
出版日 ページ情報 英文 110 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
世界の軟組織同種移植片市場の分析:移植片タイプ、用途、エンドユーザー、地域別(2018年〜2023年) Global Soft Tissue Allografts Market - Segmented by Soft Tissue Allograft Type, Application, End-User and Geography - Growth, Trends and Forecast (2018 - 2023)
出版日: 2018年08月01日 ページ情報: 英文 110 Pages
概要

世界の軟組織同種移植片市場は、2018年から2023年の予測期間を通じて約6%のCAGRで推移することが予測されています。

当レポートでは、世界の軟組織同種移植片市場を調査し、市場の概要、移植片タイプ・用途・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 市場力学

  • 成長要因
    • 高齢者人口の増加
    • 軟組織の置換技術の進歩
  • 阻害要因
    • 高額な医療費
    • 複雑な医療費償還制度
    • 滅菌の問題
  • 市場機会
  • 課題

第7章 軟組織同種移植片市場:セグメント別

  • 移植片タイプ別
    • 軟骨同種移植片
    • 腱同種移植片
    • 半月板同種移植片
    • 歯科用同種移植片
    • コラーゲン同種移植片
    • 羊膜同種移植片
  • 用途別
    • 整形外科
    • 歯科
    • 創傷治療
    • その他
  • エンドユーザー別
    • 病院
    • 美容センター
    • 整形外科クリニック
    • 外来外科センター
    • 歯科クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 企業プロファイルと競合情勢

  • Allergan Plc
  • B. Braun Melsungen AG
  • Conmed Corporation
  • Xtant Medical Holdings, Inc.
  • Alliqua BioMedical, Inc.
  • AlonSource Group
  • AlloSource
  • CR Bard, Inc.
  • Arthrex, Inc.
  • Bone Bank Allografts
  • Osiris Therapeutics, Inc.
  • Integra LifeSciences Corporation

第9章 市場の将来展望

目次
Product Code: 62796

The global soft tissue allografts market is projected to grow at a CAGR of approximately 6% during the forecast period (2018-2023). The global soft tissue allografts market is experiencing considerable growth due to factors like increasing demand for soft tissue allografts in athletics and other sports, scientific advancements in soft tissue repair and an increasing geriatric population base.

Increasing Demand for Soft Tissue Allografts in Athletics & Other Sports

Modern training regimens in athletics, field events and a number of other contact sports like the American football, require athletes to undergo intensive training sessions which are in practice more strenuous than the actual sport itself. High intensity training regimens are directly correlated with athletic performance improvement but excessive training also induces muscle and bone fatigue, and often leads to injury. Consequently, injury prevalence among athletes has been increasing especially due to excessive training. The competitive nature of sports has spurred the demand among athletes for quick recovery and easily accessible modalities to treat musculo-skeletal injuries. Consequently, the demand for soft tissue allografts has been increasing in Athletics and other contact sports, which in turn is fuelling the growth of the global soft tissue allografts market. Other factors contributing to the growth of this market include the scientific advancements in soft tissue repair and replacement, and an increasing geriatric population.

High Cost of Soft-Tissue Procedures

The average cost of functional restoration surgery and soft-tissue reconstruction in US was estimated to be between 9000 to 13,000 USD. The estimated figures for soft-tissue reconstruction is higher for lower- body extremities when compared to upper-body extremities. In addition to this, allografts are often scarce and very low quantities are synthesized in comparison to the economic resources invested in harvesting allografts. Consequently the cost of allografts themselves are subject to price fluctuation depending on their availability. High cost of soft-tissue procedures is therefore limiting the growth of the global soft tissue allografts market. Other factors which are hindering market growth includes complicated and limited reimbursement in soft-tissue allografts, and issues of tissue sterility in soft-tissue allografts.

North America has the Largest Share in Global Soft tissue Allografts Market

The global soft tissue allografts market has been segmented into five major regions, viz. North America, Europe, Asia Pacific, Middle East & Africa, and South America. Driven by the developed country of the U.S., North America dominated the global soft tissue allografts market in 2017, due to factors such as increasing prevalence of diabetic foot ulcers, better healthcare awareness program for diabetes and increase in number of surgical procedures on anterior cruciate ligament (ACL). Furthermore, technological developments on dental implants and increasing expenditure by major key players & small key players for development of soft tissue allografts are also boosting the growth of the soft tissue allografts market in North America.

Key Developments in Soft Tissue Allografts Market

Apr 2018: AlloSource in association with Stryker announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair.

Major Players: ALLERGAN PLC., B. BRAUN MELSUNGEN AG, CONMED CORPORATION, XTANT MEDICAL HOLDINGS INC., ALLIQUA BIOMEDICAL INC., ALONSOURCE GROUP, ALLOSOURCE, C. R. BARD INC., ARTHREX, INC., BONE BANK ALLOGRAFTS, OSIRIS THERAPEUTICS INC., and INTEGRA LIFESCIENCES CORPORATION among others.

Reasons to Purchase Soft Tissue Allografts Market Report

Current and future global soft tissue allografts market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players.

3-month analyst support along with the Market Estimate sheet (in Excel).

Customization of Soft Tissue Allografts Market Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Soft Tissue Allografts Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyer
    • 5.2.3 Degree of Competition
    • 5.2.4 Threat of Substitution
    • 5.2.5 Threat of New Entrants

6. Soft Tissue Allografts Market Dynamics

  • 6.1 Drivers
    • 6.1.1 Increasing Geriatric Population ( increasing prevalence of ACL tears, foots ulcers among diabetics and facial reconstruction)
    • 6.1.2 Increasing demand for Soft tissue Allografts in Athletics and Other Sports
    • 6.1.3 Scientific Advancements in Soft tissue Replacement
  • 6.2 Restraints
    • 6.2.1 High cost of Treatment
    • 6.2.2 Complicated Reimbursement Policies
    • 6.2.3 Issues in Tissue Sterility
  • 6.3 Opportunities
  • 6.4 Challenges

7. Soft Tissue Allografts Market Segmentation

  • 7.1 By Soft Tissue Allograft Type
    • 7.1.1 Cartilage Allograft
      • 7.1.1.1 Hyaline Cartilage
      • 7.1.1.2 Elastic Cartilage
      • 7.1.1.3 Fibrocartilage
    • 7.1.2 Tendon Allograft
      • 7.1.2.1 Achilles Tendon
      • 7.1.2.2 Tibialis
      • 7.1.2.3 Patellar Tendon
    • 7.1.3 Meniscus Allograft
    • 7.1.4 Dental Allograft
      • 7.1.4.1 Free Gingival Graft
      • 7.1.4.2 Connective Tissue Graft
      • 7.1.4.3 Pedicle Graft
    • 7.1.5 Collagen Allograft
    • 7.1.6 Amniotic Allograft
  • 7.2 By Application
    • 7.2.1 Orthopedic
    • 7.2.2 Dentistry
    • 7.2.3 Wound Care
    • 7.2.4 Others
  • 7.3 By End-User
    • 7.3.1 Hospitals
    • 7.3.2 Aesthetic Centers
    • 7.3.3 Orthopedic Clinics
    • 7.3.4 Ambulatory Srgical Centres
    • 7.3.5 Dental Clinics
  • 7.4 By Geography
    • 7.4.1 North America Soft Tissue Allografts Market (2018-2023)
      • 7.4.1.1 US Soft Tissue Allografts Market (2018-2023)
      • 7.4.1.2 Canada Soft Tissue Allografts Market (2018-2023)
      • 7.4.1.3 Mexico Soft Tissue Allografts Market (2018-2023)
    • 7.4.2 Europe Soft Tissue Allografts Market (2018-2023)
      • 7.4.2.1 UK Soft Tissue Allografts Market (2018-2023)
      • 7.4.2.2 Germany Soft Tissue Allografts Market (2018-2023)
      • 7.4.2.3 France Soft Tissue Allografts Market (2018-2023)
      • 7.4.2.4 Italy Soft Tissue Allografts Market (2018-2023)
      • 7.4.2.5 Spain Soft Tissue Allografts Market (2018-2023)
      • 7.4.2.6 Rest of Europe
    • 7.4.3 Asia-Pacific Soft Tissue Allografts Market (2018-2023)
      • 7.4.3.1 China Soft Tissue Allografts Market (2018-2023)
      • 7.4.3.2 India Soft Tissue Allografts Market (2018-2023)
      • 7.4.3.3 Japan Soft Tissue Allografts Market (2018-2023)
      • 7.4.3.4 Australia Soft Tissue Allografts Market (2018-2023)
      • 7.4.3.5 South Korea Soft Tissue Allografts Market (2018-2023)
      • 7.4.3.6 Rest of Asia-Pacific
    • 7.4.4 Middle East & Africa Soft Tissue Allografts Market (2018-2023)
      • 7.4.4.1 GCC Soft Tissue Allografts Market (2018-2023)
      • 7.4.4.2 South Africa Soft Tissue Allografts Market (2018-2023)
      • 7.4.4.3 Rest of Middle East & Africa
    • 7.4.5 South America Soft Tissue Allografts Market (2018-2023)
      • 7.4.5.1 Brazil Soft Tissue Allografts Market (2018-2023)
      • 7.4.5.2 Argentina Soft Tissue Allografts Market (2018-2023)
      • 7.4.5.3 Rest of South America

8. Company Profiles & Competitive Landscape

  • 8.1 Allergan Plc
  • 8.2 B. Braun Melsungen AG
  • 8.3 Conmed Corporation
  • 8.4 Xtant Medical Holdings, Inc.
  • 8.5 Alliqua BioMedical, Inc.
  • 8.6 AlonSource Group
  • 8.7 AlloSource
  • 8.8 C. R. Bard, Inc.
  • 8.9 Arthrex, Inc.
  • 8.10 Bone Bank Allografts
  • 8.11 Osiris Therapeutics, Inc.
  • 8.12 Integra LifeSciences Corporation

List Not Exhaustive

9. Soft Tissue Allografts Market Future

Back to Top